Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical has demonstrated a robust performance with a year-over-year procedure growth rate of approximately 13%, which has recently improved by 90 basis points, particularly in the U.S. general surgery market. The company has also seen significant increases in utilization rates for its robotic systems, with a notable 35% year-over-year growth in da Vinci after-hours procedures and a 21% increase in single-port utilization, reflecting rising demand across its product lines. Furthermore, Intuitive Surgical's strategies have led to higher average selling prices (ASPs) for systems, indicating a positive trend in revenue generation amidst an expanding installed base across emerging markets.

Intuitive Surgical faces a challenging outlook due to anticipated downward pressure on average selling prices (ASPs) for both systems and instruments and accessories, primarily influenced by a decline in bariatric procedures and an increase in lower-margin cholecystectomy procedures. Additionally, while the adoption of the da Vinci Surgical System (Dv5) is contributing to system revenue growth, instrumentation and accessory revenue growth is increasingly decoupled from this adoption, indicating potential vulnerabilities in the company's revenue streams. Furthermore, growth in international markets, particularly Japan, has underperformed relative to management's expectations, compounded by a slowing capital purchasing environment and heightened competition, all of which contribute to concerns regarding sustainable revenue and profitability.